Integrated Investment Consultants, LLC Myriad Genetics Inc Transaction History

Integrated Investment Consultants, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$14.51 - $20.99 $275 - $398	-19 Reduced 0.15%	12,712 $184,000
Q2 2022 Jul 19, 2022	BUY	$16.45 - $25.88 $641 - $1,009	39 Added 0.31%	12,731 $231,000
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $6,959 - $8,599	307 Added 2.48%	12,692 $320,000
Q4 2021 Jan 10, 2022	SELL	$24.13 - $32.63 $337 - $456	-14 Reduced 0.11%	12,385 $342,000
Q3 2021 Oct 28, 2021	BUY	$29.97 - $36.66 $4,555 - $5,572	152 Added 1.24%	12,399 $400,000
Q2 2021 Jul 21, 2021	SELL	$25.39 - $32.61 $79,445 - $102,036	-3,129 Reduced 20.35%	12,247 $375,000
Q1 2021 Apr 20, 2021	BUY	$19.92 - $31.6 $89,640 - $142,200	4,500 Added 41.38%	15,376 $468,000
Q4 2020 Feb 09, 2021	BUY	$12.16 - $19.77 $158 - $257	13 Added 0.12%	10,876 $215,000
Q3 2020 Oct 26, 2020	BUY	$11.25 - $14.75 $122,208 - $160,229	10,863 New	10,863 $142,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.22B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Investment Consultants, LLC with notifications on news.